[1] Weng Q, Duoduo W, Peng G, et al. Q39, a novel synthetic quinoxaline 1,4-di-N-oxide compound with anticancer activity in hypoxia[J]. Eur J Pharmacol, 2008, 581(3):262-269. [2] Azquetta A, Arbillaga L, Pachon G,et al. A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment[J]. Chem Biol Interact, 2007, 168(2):95-105. [3] Ghosh A, Mandal S, Chattaraj PK, et al. Ring expansion of donor-acceptor cyclopropane via substituent controlled selective N-transfer of (1R) -(-) -(10-camphorsulfonyl)oxaziridine:synthetic and mechanistic insights[J]. Org Lett, 2016,18(19):4940-4943. [4] Aydi R, Gara AB, Chaaben R, et al. Hypolipidemic effect of dihydroisoquinoline oxaziridine in high-fat diet-fed rats[J]. Biomed Pharmacother, 2016, 82:660-668. [5] Naganawa Y, Aoyama T, Nishiyama H. Cu(ii)-catalyzed enantioselective oxygen atom transfer from oxaziridine to oxindole derivatives with chiral phenanthroline[J]. Org Biomol Chem, 2015, 13(47):11499-11506. [6] Ouédraogo M, De Maesschalck ED, Soentjens-Werts V, et al. In vitro cytotoxicity study of oxaziridines generated after chlordiazepoxide, demoxepam, and desmethylchlordiazepoxide UV irradiation[J]. Drug Chem Toxicol, 2009, 32(4):417-423. [7] 孔赛,韩凤娟,张志刚.中药抗宫颈癌HPV感染的研究进展[J]. 世界中西医结合杂志, 2014, 9(3):319-322. [8] Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalenceof cancer for 25 sites in the adult population[J]. Int J Can cer, 2002, 97(1):72-81. [9] 赵峰,刘培勋.中药抗肿瘤及其转移机制研究进展[J].中国中西医结合杂志, 2007, 27(2):178-181. [10] Tewari KS, Sill MW, Long HR, et al. Improved survival with bevacizumab in advanced cervical cancer[J]. N Engl J Med, 2014, 370(8):734-743. [11] Hengartner MO. The biochemistry of apoptosis[J]. Nature, 2000,407(6805):770-776. |